Allen Clermont
About Allen Clermont
Allen Clermont serves as the Director of Preclinical Pharmacology at KalVista Pharmaceuticals, Inc., a position he has held since 2022. With extensive experience in research and pharmacology, he has worked at notable institutions including Massachusetts General Hospital and Harvard Medical School.
Work at KalVista Pharmaceuticals
Allen Clermont currently serves as the Director of Preclinical Pharmacology at KalVista Pharmaceuticals, Inc., a position he has held since 2022. Prior to this role, he worked at KalVista as the Associate Director of Preclinical Pharmacology for 11 months and as Principal Scientist in In Vivo Pharmacology and Target Validation for 10 months. His work focuses on developing in vivo models that facilitate target validation and support the transition of discoveries from the laboratory to clinical trials.
Education and Expertise
Allen Clermont earned his Bachelor of Science in Electrical Engineering and a Master of Science in Biomedical Engineering from Worcester Polytechnic Institute, completing his studies from 1981 to 1988. His academic background provides him with a solid foundation in both electrical and biomedical engineering. He has developed expertise in creating in vivo models for target validation, which are essential for advancing research into clinical applications.
Background
Allen Clermont has extensive experience in the field of medical research, having worked at various prestigious institutions. He was involved in cardiology research at Massachusetts General Hospital from 2001 to 2006. Additionally, he spent 32 years at Joslin Diabetes Center, where he held several roles, including Research Associate and Assistant Physiology Core Director. He also served as an Associate in Medicine at Harvard Medical School for 19 years, gaining significant experience in physiology and translational medicine.
Achievements
Throughout his career, Allen Clermont has contributed to the development of biological models in translational medicine, utilizing his microsurgical skills. He is skilled in leading research from bench top discoveries to clinical trials, showcasing his ability to bridge the gap between laboratory research and practical medical applications. His work has implications for advancing understanding in pharmacology and improving clinical outcomes.